d-alpha tocopherol has been researched along with Opioid-Related Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Díaz Romero, C; Díaz-Flores Estévez, F; Díaz-Flores Estévez, JF; Hernández Calzadilla, C; Rodríguez Rodríguez, EM; Serra-Majem, L | 1 |
| Ito, S; Matsubayashi, K; Mori, T; Sawaguchi, T | 1 |
2 other study(ies) available for d-alpha tocopherol and Opioid-Related Disorders
| Article | Year |
|---|---|
Application of linear discriminant analysis to the biochemical and haematological differentiation of opiate addicts from healthy subjects: a case-control study.
Topics: Adult; alpha-Tocopherol; Ascorbic Acid; Case-Control Studies; Discriminant Analysis; Female; Health Status; Hematologic Tests; Humans; Male; Methadone; Middle Aged; Minerals; Opioid-Related Disorders; Vitamin A; Vitamin B 12; Vitamins | 2004 |
Comparison of nitric oxide synthase inhibitors, phospholipase A2 inhibitor and free radical scavengers as attenuators of opioid withdrawal syndrome.
Topics: alpha-Tocopherol; Animals; Ascorbic Acid; Enzyme Inhibitors; Free Radical Scavengers; Hydroxyl Radical; Male; Mice; Naloxone; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Opioid-Related Disorders; Phospholipase A2 Inhibitors; Substance Withdrawal Syndrome; Superoxides | 2007 |